H47.622

Clinical Causes: Multiple sclerosis (MS) Viral or bacterial encephalitis Autoimmune inflammatory conditions Neuro-inflammatory responses secondary to infections Trauma-induced inflammation Other inflammatory or demyelinating diseases affecting the brain

Key Symptoms: Partial or complete loss of vision in the affected visual field Visual field defects such as hemianopia (loss of half of the visual field) Visual agnosia (difficulty recognizing objects, faces, or colors) Difficulty perceiving motion or depth Visual hallucinations or distortions Drowsiness or confusion if inflammation is severe Other neurological signs such as weakness or sensory disturbances (if inflammation extends beyond the visual cortex)

Diagnosis Path: Diagnosis typically involves a combination of clinical evaluation and imaging studies. The process includes: - Neurological examination focusing on visual and cognitive function - Magnetic resonance imaging (MRI) scans of the brain to visualize inflammation or lesions in the occipital lobe - Blood tests to identify markers of inflammation or underlying autoimmune conditions - Lumbar puncture (spinal tap) to analyze cerebrospinal fluid for signs of infection or inflammation - Additional tests such as visual field testing or EEG may be used to assess functional impact Proper diagnosis requires identifying the specific inflammatory condition affecting the visual cortex to tailor management strategies effectively.

Treatment Protocols: Treating disorders of the visual cortex caused by inflammation involves addressing the underlying inflammatory process and managing symptoms. Common approaches include: - Corticosteroids to reduce brain inflammation and swelling - Immunosuppressive therapies if an autoimmune process is identified - Antiviral or antibacterial medications for infectious causes - Supportive therapies such as visual rehabilitation and physical therapy - Managing associated neurological symptoms and complications - Regular monitoring through imaging and neurological assessments It is essential to work closely with healthcare professionals to develop an appropriate treatment plan tailored to the specific inflammatory condition and its severity, aiming to preserve or improve visual function and overall neurological health.